| Subject: | Recall of Invanz (ertapenem sodium) Injection |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Fri, 6 Jul 2007 - 06:00 am |
| Audience: Infectious disease specialists, hospital administrators and pharmacists, other healthcare professionals Merck and the FDA have informed healthcare professionals that three (3) lots of Invanz (0803930, 0803940, and 0803950) have been recalled. The lots have an expiration date of October 2008. Invanz is indicated for the treatment of patients with moderate to severe infections caused by susceptible isolates of the designated microorganisms.The product was recalled because of two... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
External Links:
|
|
With over 20 years experience in regulatory compliance, MCN Healthcare brings you the most comprehensive regulatory compliance tool available. StayAlert! is the only comprehensive e-mail notification service available that not only notifies you of the changes in major federal regulations, but also provides the policies, procedures, tools and best practices to help you meet the changing regulation. StayAlert! actively monitors TJC (JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG and many others so you don't have to. The strength of StayAlert! rests in its ability to allow healthcare organizations to streamline their businesses using the Internet as a foundation architecture. StayAlert! provides cost containment and reduction through elimination of unnecessary overhead, and work caused by errors or poor access to information. |
|
